Jirong Peng,Michael John Costanzo,Michael Nicholas Greco,Michael Alan Green,Victoria Lynn Wilde,Don Zhang
申请号：
US16819539
公开号：
US20200216421A1
申请日:
2020.03.16
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This application discloses novel substituted 2-anilinopyrimidine derivatives, and pharmaceutically acceptable salts, solvates, prodrugs, and compositions thereof, which are useful for the treatment or prevention of diseases or medical conditions mediated by epidermal growth factor receptors (EGFRs), including but not limited to a variety of cancers.
